Latest Options News

Matsa Resources has confirmed the unconditional status of its A$113 million option agreement with AngloGold Ashanti for the Lake Carey Gold Project, triggered by rising gold prices and strategic payments.

African Gold Ltd has announced a remarkable 119% increase in the inferred gold resource at its Blaffo Guetto prospect in Cote d’Ivoire, now approaching 1 million ounces. With $12 million in funding secured, the company is set to accelerate drilling to unlock further potential across the Didievi Project.

Invion Limited has announced a fully underwritten entitlement offer of Loyalty Options to raise capital for advancing its cancer clinical trials. The offer, led by Blue Ocean Equities and supported by CEO Prof Thian Chew, invites eligible shareholders to participate in a non-renounceable rights issue.

Noble Helium has amended its convertible note terms with Obsidian Global, postponing share conversions until refinancing or September 2025, while issuing new shares and options as part of a strategic turnaround.

Vection Technologies has secured a $2.6 million contract to co-develop SAFE-XR, an AI-powered safety compliance platform using augmented reality and wearable tech for industrial inspections in Italy.

Critica Limited has entered a farm-in agreement with Ausgold Limited for its Kulin Gold Project, allowing Ausgold to earn up to 70% interest by funding exploration. This strategic move enables Critica to concentrate resources on its flagship Jupiter Rare Earth Element Project, Australia's largest high-grade clay-hosted rare earth deposit.

Sunshine Metals has exercised its option early to acquire the Sybil Epithermal Gold Project, setting the stage for drilling to commence in July-August 2025. The project boasts historic high-grade gold results and strategic significance near Charters Towers.

Metcash Limited has announced a fully franked ordinary dividend of AUD 0.095 per share for the fiscal year ending April 2025, accompanied by a Dividend Reinvestment Plan offering.

Stockland has announced an estimated unfranked dividend of AUD 0.172 per security for the first half of FY25, accompanied by a Dividend Reinvestment Plan offering a 1% discount.

Immutep reports promising Phase I results for IMP761, a novel LAG-3 agonist antibody demonstrating significant T cell inhibition and a clean safety profile, advancing hopes for new autoimmune disease treatments.

Richmond Vanadium Technology slows key project activities and reshapes its leadership team to navigate a prolonged period of low vanadium prices while advancing battery technology development.

Ausgold Limited has secured a farm-in agreement to acquire up to 70% of a highly prospective exploration license adjacent to its Kulin Gold Project, setting the stage for drilling in FY26 to unlock new gold targets.